Delivery Order 36F79721D0239-36C24523N0549
Award Date
5/4/23
Potential Completion Date
5/8/23
Potential Value
$12K
Federal Agency
Veterans Integrated Service Network 5
Awardee
Travere Therapeutics, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92130, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $30,564.10 delivery order to Travere Therapeutics, Inc. for THIOLA 100 MG. The contract was issued against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), has a firm fixed price, place of performance in San Diego, California, and completion date of September 26, 2022. No set-aside designation was used for this order to supply the drug THIOLA 100 MG in support of...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $28,372.89 delivery order to Travere Therapeutics, Inc. under the Pharmaceuticals and Drugs Federal Supply Schedule contract. The firm fixed price order is for the delivery of THIOLA 100 MG to a location in San Diego, California, with an expected completion date of October 18, 2021. No set-aside designation was used for this award made on October 15, 2021 to supply needed...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $30,564.10 delivery order to Travere Therapeutics, Inc. for the pharmaceutical product THIOLA 100 MG. The contract was awarded on June 29, 2022 with a completion date of June 30, 2022. It utilizes the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) vehicle and has a firm fixed price. Performance will take place in San Diego, California. No set-aside designation was used...
This delivery order from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awards Travere Therapeutics, Inc. $10,915.75 to provide Thiola medication for patient use. Issued against the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB), this firm fixed price contract has a total small business set aside designation and is to be completed by December 22, 2022. The place of performance is in San Diego, California, where Travere Therapeutics...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $12,000 delivery order to Travere Therapeutics, Inc. under the company's Pharmaceuticals and Drugs GSA Schedule contract. The order is for THIOLA 100 MG and will be fulfilled by Travere Therapeutics, Inc. Division in San Diego, California over a three-day period from November 3rd through 6th, 2023. The contract has a firm fixed price and will support the VA-VHA's medical programs...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $25,983.23 delivery order to Travere Therapeutics, Inc. for the pharmaceutical product Thiola 100 MG. The contract was awarded on June 12, 2023 and is set to be completed by June 16, 2023. It utilizes the Pharmaceuticals and Drugs Federal Supply Schedule known as FSS-61-IB, and pricing is firm fixed price. Performance will take place in San Diego, California. No set-aside designation...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $17,988 delivery order to Travere Therapeutics, Inc. under the company's Pharmaceuticals and Drugs GSA Schedule contract. Travere Therapeutics will provide 100mg doses of the drug THIOLA to the VA medical center in San Diego, California between September 21-26, 2023. The firm fixed price order is being funded by VHA to support its mission of providing healthcare services to...
This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) to Travere Therapeutics, Inc., a biopharmaceutical company that specializes in developing and delivering therapies for rare diseases. The contract, valued at $87,515.28, is for the procurement of the drug tiopronin (Thiola) for the VA's pharmacy ordering requirements in fiscal year 2018. The contract was awarded under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and does not...
This federal contract award to Travere Therapeutics, Inc., a biopharmaceutical company, is for the supply of Thiola 100 mg, a pharmaceutical product used to treat rare medical conditions. The contract, awarded by the Department of Veterans Affairs (VA), Veterans Integrated Service Network 5, is a firm fixed-price delivery order with a ceiling value of $32,838.56 and a period of performance through February 14, 2025. The contract is issued under the Pharmaceuticals and Drugs Federal Supply...
The U.S. Department of Veterans Affairs (VA) has awarded a firm fixed price delivery order contract to Travere Therapeutics, Inc., a biopharmaceutical company that specializes in rare disease therapies. The contract, valued at $11,125.32, is for the supply of the pharmaceutical drug Thiola 100 mg. This delivery order is placed against Travere Therapeutics' Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract with the VA. Travere Therapeutics also holds a $25 million Blanket...